Taizhou Mabtech Pharmaceutical Co.,ltd

This early-phase study tests a new drug called CMAB017 in about 55 people with advanced solid tumors (like head and neck, colorectal, or esophageal cancer) that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug…